2-(4-((4-bromophenyl)sulfonyl)piperazin-1-yl)ethanol

Catalog No. :
ACUELJ445
CAS No. :
524718-84-1
Molecular Formula :
C12H17BrN2O3S
Molecular Weight :
349.25

IUPAC Name:2-(4-((4-bromophenyl)sulfonyl)piperazin-1-yl)ethan-1-ol

2-(4-((4-bromophenyl)sulfonyl)piperazin-1-yl)ethanol structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
50mg95%$100.00Login to see priceInquiryInquiry
100mg95%$140.00Login to see priceInquiryInquiry
250mg95%$194.00Login to see priceInquiryInquiry
1g95%$478.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2-(4-((4-bromophenyl)sulfonyl)piperazin-1-yl)ethanol
IUPAC Name2-(4-((4-bromophenyl)sulfonyl)piperazin-1-yl)ethan-1-ol
MDL No.MFCD03502909
Molecular FormulaC12H17BrN2O3S
Molecular Weight349.25
SMILESO=S(N1CCN(CCO)CC1)(C2=CC=C(Br)C=C2)=O
InChI KeyZFNQGKTVXQQEEJ-UHFFFAOYSA-N
Synonym2-(4-((4-broMophenyl)sulfonyl)piperazin-1-yl)ethanol;2-{4-[(4-bromophenyl)sulfonyl]-1-piperazinyl}ethanol;1-Piperazineethanol, 4-[(4-bromophenyl)sulfonyl]-;2-[4-(4-Bromobenzenesulfonyl)piperazin-1-yl]ethan-1-ol
CAS No.524718-84-1

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACUELJ445 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACUELJ445 route product structure diagram
    ACUELJ445524718-84-1
Inquiry

2. ACUELJ445 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACUELJ445 route product structure diagram
    ACUELJ445524718-84-1
Inquiry

Comments (0)